Institutional Equities

Similar documents
EBITDA 5,019 4,211 5, EBITDA

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

Institutional Equities

EBITDA 5,076 3, , EBITDA

3,746 2,551 3, NIM

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Punjab National Bank

9,251 7,812 8, NIM

Institutional Equities

Dalmia Bharat Enterprises

9,807 8,007 9, NIM

Institutional Equities

Institutional Equities

Punjab National Bank

93,707 77,814 90, NIM

Jamna Auto Industries

E&P To Stay Strong; Consumer Segment To Revive

Institutional Equities

Swiss Glascoat Equipments

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Indian Oil Corporation

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

Punjab National Bank

Gillette India. Institutional Equities. 1QFY18 Result Update

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

Colgate-Palmolive (India)

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

Dalmia Bharat Enterprises

Dalmia Bharat Enterprises

EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

EBITDA 6,223 6,511 (4.4) 5, EBITDA

State Bank of India. Institutional Equities. 1QFY18 Result Update

Institutional Equities

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21%

La Opala RG. Institutional Equities. 1QFY18 Result Update

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Indian Oil Corporation

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Institutional Equities

Punjab National Bank

Voltas. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Capital Goods CMP: Rs309 Target Price: Rs325 Upside: 5% 23 December 2016

JBF Industries. Institutional Equities. 1QFY16 Result Update BUY. Healthy Gross Profit Growth, But Other Costs Higher; Retain Buy

Sun Pharmaceutical Industries

Punjab National Bank

The Ramco Cements. Institutional Equities. Event Update BUY

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Institutional Equities

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

KEC International. Institutional Equities. Management Meet Update BUY. On Course Towards Recovery In Operating Margin

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Persistent Systems. Institutional Equities. Management Meet Update SELL. Watson IOT Bet Risk/Reward More Muted Than Anticipated

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

TD Power Systems. Institutional Equities. Company Update BUY

FY11 FY12 FY13E FY14E

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Institutional Equities

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

2,09,057 1,85,859 2,17, (4.1) NIM

Dabur India. Institutional Equities. 1QFY19 Result Update

KEC International. Institutional Equities. Management Meet Update. Healthy Order Inflow Traction Expected To Continue BUY

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Tata Consultancy Services

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

Apar Industries. Institutional Equities. Management Meet Update. In Turnaround Mode; Retain Buy BUY

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Bharat Heavy Electricals

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Bharat Heavy Electricals

Bharat Financial Inclusion

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

Bharat Heavy Electricals

9,500 7,914 8, NIM

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

Huhtamaki PPL. Institutional Equities. Management Meet Update NOT RATED. CMP: Rs186 Sector: Packaging. 16 September 2014

Institutional Equities

18,948 15,784 18, NIM

Transcription:

2QFY18 Result Update Institutional Equities KCP 5 December 2017 Reuters: KCP.BO; Bloomberg: KCPL IN Other Income Drives PAT; High International Coal Price Is Cause For Concern KCP reported a weak set of numbers for 2QFY18 on account of high operating costs and low realisation. KCP posted volume of 0.5mnmt, a growth of 20% YoY on account of increased construction activity in its addressable market. Revenues stood at Rs2,503mn, above our estimate of Rs2,280mn. However, realisation declined 11% YoY. Operating costs increased 17% QoQ and 30% YoY on account of high freight, employee and power & fuel costs. At the conference call, KCP also stated that the rise in international coal prices affected the bottomline of cement business. As a result, KCP reported EBITDA of Rs341mn, below our expectation of Rs366mn. The engineering division reported revenues of Rs254mn with EBIT loss of Rs45mn. The order book of engineering division increased to Rs1,000mn versus Rs800mn in the previous quarter. At the conference call, the management stated that hotel operations started improving and the occupancy rate increased substantially which helped the company to report hotel segment revenues of Rs34.4mn, up 4% QoQ, and EBIT loss of Rs23mn against EBIT loss of Rs25mn in the previous quarter. Despite incurring losses in engineering and hotel businesses, KCP reported PAT of Rs360mn, mostly on account of higher other income of Rs386mn, which includes dividend received amounting to Rs380mn from its subsidiary in Vietnam. KCP has planned brownfield expansion with a capex of Rs5bn, out of which Rs1.3bn has been incurred which will increase its Muktyla plant capacity from 1.8mnmt to 3.3mnmt and overall capacity to 4.2mnmt. However, the management at the conference call stated that international coal prices have increased substantially which is a cause for concern and may hurt the power business and affect bottom-line of cement business. Also, the company may not be able to pass on the increase in operating costs to consumers because of the rise in international coal prices which may hurt profitability in near future. Therefore, we have introduced our FY20 estimates with sales/ebitda/pat estimates at Rs12.3bn/Rs2.4bn/Rs0.7bn, respectively. We have maintained our target multiples on the stock at 1HFY20 EV/EBITDA of 7.0x and 1HFY20 target EV/mt of US$90. We have retained Accumulate rating on the stock with a target price of Rs126. Conference-call highlights: The management stated at the conference call that KCP is going for brownfield expansion with a capital expenditure of Rs 5bn, which will be financed partly with debt of Rs2bn to Rs2.5bn and the rest with own generated funds. However, the management didn t disclose about whether this is for clinker capacity expansion or grinding unit capacity expansion. On cement demand outlook, the company stated that the outlook is good in Andhra Pradesh and Telangana, but it does not expect realisation growth like it was in 1QFY18. As regards sugar business, the management stated that KCP will go for further capex of Rs650mn-Rs700mn which will be completed by 3QFY19 (which is just bottlenecking of certain facilities) but also stated that sugar prices are easing in the market which may affect profitability on a consolidated basis. The management stated that the company is only concerned about international coal prices which have increased substantially. Therefore, the increase in international coal prices may hurt the bottom-line of cement industry and KCP may not be able to pass them to the consumer. Outlook: With a capacity expansion plan and increase in operating costs because of the rise in international coal prices, we have retained our target price of Rs126 on AAL. We have also retained our target multiples on the stock at 1HFY20E EV/EBITDA of 7.0x and 1HFY20 target EV/mt of US$90. We have retained Accumulate rating on KCP with a target price Rs126. ACCUMULATE Sector: Cement CMP: Rs120 Target Price: Rs126 Upside: 5% Harshit Dhoot harshit.dhoot@nirmalbang.com +91-22-3926 8111 Key Data Current Shares O/S (mn) 128.9 Mkt Cap (Rsbn/US$mn) 15.4/239.5 52 Wk H / L (Rs) 138/80 Daily Vol. (3M NSE Avg.) 257,182 Price Performance (%) 1 M 6 M 1 Yr KCP (2.3) 13.9 40.8 Nifty Index (3.1) 4.7 24.6 Source: Bloomberg Y/E March (Rsmn) (standalone) 2QFY17 1QFY18 2QFY18 YoY (%) QoQ (%) Net sales 2,038 2,368 2,503 5.7 5.7 Total expenses 1,667 1,849 2,162 16.9 16.9 EBITDA 371 519 341 (34.2) (34.2) EBITDA margin (%) 18.2 21.9 13.6 (827) (37.8) Net other income 12 14 376 2,512.5 2,512.5 Interest costs 120 104 91 (12.4) (12.4) Depreciation 130 120 117 (2.8) (2.8) PBT 133 309 509 65.0 65.0 Tax 47 85 149 75.7 75.7 Tax rate (%) 36 28 - - PAT 86 224 360 61.0 61.0 Adjusted profit 73 224 360 61.0 61.0

Exhibit 1: Detailed financials (Rsmn) 2QFY17 1QFY18 2QFY18 YoY (%) QoQ (%) Net sales 2,038 2,368 2,503 22.8 5.7 Expenditure Raw material costs 500 428 359 (28.2) (16.1) Chg. in stock 111 (65) 204 84.0 (412.9) Stores and spares 114 - - (100.0) - Employee costs 192 212 295 53.5 39.2 Power and fuel costs 302 614 546 80.4 (11.1) Freight costs 263 316 472 79.0 49.1 Other expenses 185 344 287 55.6 (16.6) Total expenses 1,667 1,849 2,162 29.7 16.9 EBITDA 371 519 341 (8.1) (34.2) EBITDA margin % 18.2 21.9 13.6 (457.8) (827.1) Other income 12 14 376 3,115.4 2,512.5 Interest costs 120 104 91 (24.0) (12.4) Depreciation 130 120 117 (10.0) (2.8) Exceptional items (13) - - - - PBT 133 309 509 283.0 65.0 Tax 47 85 149 - - Tax rate 36 28 - - - PAT 86 224 360 320.8 61.0 Adjusted profit 73 224 360 394.1 61.0 Exhibit 2: Segmental performance in 2QFY17 (Rsmn) Revenues EBIT Margin (%) Engineering 254 (45) (18) Cement 2,191 269 12 Power 188 7 4 Hotel 34 (23) (67) Others 393 404 103 Total 3,060 611 20 Exhibit 3: Change in our estimates (Rsmn) Old New Deviation (%) FY18E FY19E FY18E FY19E FY20E FY18E FY19E Net sales 9,179 10,610 9,179 10,610 12,288 - - Operating profit 7,577 8,639 7,577 8,639 9,901 - - Net profit 403 509 403 509 2,387 - - EPS (Rs) 3.1 3.9 3.1 3.9 5.6 - - Target price (Rs) 126 126 - - Rating Accumulate Accumulate - - Source: Nirmal Bang Institutional Equities Research Exhibit 4: Deviation from our estimates 2QFY18 (Rsmn) Actual Our estimate Deviation (%) Net sales 2,503 2,280 10 Operating expenses 2,162 1,849 13 EBITDA 341 366 (7) EBITDA margin (%) 16.0 13.6 240bps Adjusted PAT 360 102 253 NPM (%) 14.4 4.5 91 EPS (Rs) 2.79 0.79 253 Source: Nirmal Bang Institutional Equities Research 2 KCP

Exhibit 5: Target price of Rs126 offers 5% upside from current market price Particulars (Rsmn) Value of cement business 20,181 Value of 67% stake in sugar business 2,565 Value of hotel business 540 Total enterprise value 23,286 Less: Net debt 7,026 Total equity value 16,259 No. of shares (mn) 129 Target price (Rs) 126 CMP (Rs) 120 Upside (%) 5.1 3 KCP

Standalone financials Exhibit 6: Income statement Y/E March (Rsmn) FY16 FY17E FY18E FY19E FY20E Net sales 7,498 8,219 9,179 10,610 12,288 Raw material costs 2,075 2,291 2,603 3,028 3,522 Employee costs 663 703 745 790 845 Selling & distribution 987 1,204 1,348 1,548 1,793 expensesexpenses Power and fuel costs 1,191 1,554 1,807 2,112 2,485 Other expenses 387 307 316 326 336 Total expenses 6,031 6,763 7,577 8,639 9,901 Operating profit 1,467 1,456 1,601 1,971 2,387 Operating profit margin (%) 19.6 17.7 17.4 18.6 19.4 Other income 38 42 46 51 56 Interest costs 454 454 609 729 730 Depreciation 391 463 479 587 706 PBT 660 581 559 707 1,006 Exceptional items (6) - - - - PBT post exc. items 654 581 559 707 1,006 Tax 226 163 157 198 282 Tax rate (%) 34 28 28 28 28 PAT 428 418 403 509 725 EPS (Rs) 3.3 3.2 3.1 3.9 5.6 Exhibit 8: Balance sheet Y/E March (Rsmn) FY16 FY17E FY18E FY19E FY20E Equity capital 129 129 129 129 129 Reserves and surplus 3,745 4,035 4,309 4,689 5,285 Net worth 3,874 4,164 4,438 4,818 5,414 Total debt 3,908 4,708 6,858 7,658 7,658 Deferred tax liability 872 872 872 872 872 Current liabilities 1,421 1,645 1,839 2,089 2,384 Other liabilities 428 446 464 484 504 Total liabilities 10,502 11,834 14,471 15,920 16,832 Gross block 10,087 10,487 10,787 15,287 16,087 Acc. Depr. 3,031 3,494 3,973 4,559 5,265 Net block 7,056 6,993 6,814 10,728 10,822 CWIP 105 750 3,250 50 50 Investment 289 289 289 289 289 Current assets less cash 2,126 2,775 3,101 3,519 4,013 Cash 189 252 203 481 762 Total assets 10,502 11,834 14,471 15,920 16,832 Exhibit 7: Cash flow Y/E March (Rsmn) FY16 FY17E FY18E FY19E FY19E PAT 428 418 403 509 725 Add: Depreciation 391 463 479 587 706 Chg. in NWC 161 (462) (170) (209) (241) Cash flow from operations 981 419 711 887 1,189 Capex (604) (1,045) (2,800) (1,300) (800) Chg. in Investment - - - - - Cash flow from investing (604) (1,045) (2,800) (1,300) (800) Issue of shares - - - - - Issue of pref. stock - - - - - Inc. in debt (583) 800 2,150 800 - Inc. in DTL 199 - - - - Dividend paid (129) (129) (129) (129) (129) Cash flow from financing (516) 689 2,040 691 (108) Net cash flow (139) 63 (49) 278 281 Opening cash balance 328 189 252 203 481 Closing cash balance 189 252 203 481 762 Exhibit 9: Key ratios Y/E March (Rsmn) FY16 FY17E FY18E FY19E FY20E Growth (%) Sales 23.5 9.6 11.7 15.6 15.8 Operating profit 50.2 (0.7) 10.0 23.1 21.1 Net profit 161.0 (2.3) (3.8) 26.4 42.3 Leverage (x) Debt:equity 1.0 1.1 1.5 1.6 1.4 Net debt:equity 1.0 1.1 1.5 1.5 1.3 Profitability (%) OPM 19.6 17.7 17.4 18.6 19.4 NPM 5.7 5.1 4.4 4.8 5.9 RoE 11.5 10.4 9.4 11.0 14.2 RoCE 12.2 10.7 10.2 10.9 12.3 Valuation (x) P/E 34.3 35.1 38.4 30.4 21.4 P/BV 3.8 3.5 3.5 3.2 2.9 EV/EBITDA 12.6 13.2 13.8 11.5 9.4 4 KCP

Apr-15 Jun-15 Aug-15 Oct-15 Dec-15 Jan-16 Apr-16 Jun-16 Aug-16 Oct-16 Dec-16 Jan-17 Apr-17 Jun-17 Aug-17 Oct-17 Dec-17 Institutional Equities Rating track Date Rating Market price (Rs) Target price (Rs) 17 March 2016 Buy 74 103 31 May 2016 Buy 79 122 10 August 2016 Buy 90 122 16 November 2016 Buy 90 125 8 February 2017 Buy 100 126 23 May 2017 Accumulate 112 126 5 December 2017 Accumulate 120 126 Rating track graph 140 130 120 110 100 90 80 70 60 50 40 Not Covered Covered 5 KCP

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is published by Nirmal Bang s Institutional Equities Research desk. Nirmal Bang group has other business units with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. Reports based on technical and derivative analysis may not match with reports based on a company's fundamental analysis. This report is for the personal information of the authorised recipient and is not for public distribution. This should not be reproduced or redistributed to any other person or in any form. This report is for the general information for the clients of Nirmal Bang Equities Pvt. Ltd., a division of Nirmal Bang, and should not be construed as an offer or solicitation of an offer to buy/sell any securities. We have exercised due diligence in checking the correctness and authenticity of the information contained herein, so far as it relates to current and historical information, but do not guarantee its accuracy or completeness. The opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. Nirmal Bang or any persons connected with it do not accept any liability arising from the use of this document or the information contained therein. The recipients of this material should rely on their own judgment and take their own professional advice before acting on this information. Nirmal Bang or any of its connected persons including its directors or subsidiaries or associates or employees or agents shall not be in any way responsible for any loss or damage that may arise to any person/s from any inadvertent error in the information contained, views and opinions expressed in this publication. Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) is a registered Member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited. NBEPL has registered with SEBI as a Research Entity in terms of SEBI (Research Analyst) Regulations, 2014. (Registration No: INH000001436-19.08.2015 to 18.08.2020). NBEPL or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. NBEPL or its associates/analyst has not received any compensation from the company covered by Analyst during the past twelve months. NBEPL /analyst has not served as an officer, director or employee of company covered by Analyst and has not been engaged in market-making activity of the company covered by Analyst. The views expressed are based solely on information available publicly and believed to be true. Investors are advised to independently evaluate the market conditions/risks involved before making any investment decision. Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 3926 8017 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 3926 8230, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 3926 8100/8101, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 3926 8102/8103, +91 22 6636 8830 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 301/302, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-400013. Board No. : 91 22 3926 8000/1; Fax. : 022 3926 8010 6 KCP